Black Diamond Therapeutics (BDTX)
(Delayed Data from NSDQ)
$6.46 USD
+0.34 (5.56%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $6.50 +0.04 (0.62%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $-0.35 | -0.20% |
Earnings Summary
For their last quarter, Black Diamond Therapeutics (BDTX) reported earnings of -$0.36 per share, beating the Zacks Consensus Estimate of $-0.39 per share. This reflects a positive earnings surprise of 7.69%. Look out for BDTX's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of -$0.35 per share, reflecting a year-over-year increase of 22.22%.
Earnings History
Price & Consensus
Zacks News for BDTX
Should You Buy Black Diamond Therapeutics (BDTX) Ahead of Earnings?
BDTX: What are Zacks experts saying now?
Zacks Private Portfolio Services